Natural Killer(NK) Cell Therapy Targeting CLL1 or CD33 in Acute Myeloid Leukemia

Conditions: AML, Adult Interventions: Biological: iPSC-NK cells Sponsors: Zhejiang University; Hangzhou Qihangene Biotech Co.,Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials